Additionally, the analysis considers HER2 (+) (Human Epidermal Growth Factor Receptor 2 Positive, indicating high levels of HER2 protein in the cancer cells) and HER2 (−) samples when both ER and PR are negative. This evidence concerns the gene ESR1 and cancer.